References
- Bedognetti D, Wang E, Sertoli MR, Marincola FM. Gene expression profiling in vaccine therapy and immunotherapy for cancer. Expert Rev. Vaccines9(6), 555–565 (2010).
- Burbelo PD, Ching KH, Bush ER, Han BL, Iadarola MJ. Antibody profiling technologies for studying humoral responses to infectious agents. Expert Rev. Vaccines9(6), 567–578 (2010).
- von Mensdorff-Pouilly S. Vaccine-induced antibody responses in patients with carcinoma. Expert Rev. Vaccines9(6), 579–594 (2010).
- Plebanski M, Katsara M, Sheng K-C, Xiang SD, Apostolopoulos V. Methods to measure T-cell responses. Expert Rev. Vaccines9(6), 595–600 (2010).
- Zaritskaya L, Shurin MR, Sayers TJ, Malyguine AM. New flow cytometric assays for monitoring cell-mediated cytotoxicity. Expert Rev. Vaccines9(6), 601–616 (2010).
- Cebon J, Knights A, Ebert L, Jackson H, Chen W. Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1. Expert Rev. Vaccines9(6), 617–629 (2010).
- Wu S, Jin L, Vence L, Radvanyi LG. Development and application of ‘phosphoflow’ as a tool for immunomonitoring. Expert Rev. Vaccines9(6), 631–643 (2010).
- Hearty S, Conroy PJ, Ayyar BV, Byrne B, O’Kennedy R. Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends. Expert Rev. Vaccines9(6), 645–664 (2010).
- Flanagan KL, Burl S, Lohman-Payne BL, Plebanski M. The challenge of assessing infant vaccine responses in resource-poor settings. Expert Rev. Vaccines9(6), 665–674 (2010).